Previous 10 | Next 10 |
home / stock / medif / medif news
TORONTO, Oct. 03, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is...
You can count the number of marijuana-focused exchange-traded funds (ETFs) on your fingers. And you can count the number of relatively large marijuana ETFs on your thumbs. Only two have net assets of at least $500 million -- ETFMG Alternative Harvest ETF (NYSEMKT: MJ) and Horizo...
MediPharm stock is trading down slightly despite MediPharm Labs (TSX:LABS) (OTCQX:MEDIF) increasing its exports of medical cannabis concentrate to Australia. MediPharm Stock Down on Australia Expansion MediPharm Labs Corp, a Canadian market leader in cannabis extraction a...
Listen on the go! Subscribe to The Cannabis Investing Podcast on Apple Podcasts , Google Podcasts , Spotify , and Stitcher . By Jonathan Liss Today's guest will be familiar to many investors both within and outside of the cannabis space. Tim Seymour of CNBC...
On the one hand, marijuana is supposed to be the greatest growth opportunity since sliced bread . Worldwide sales of cannabis have more than tripled over the past four years, and they could grow anywhere from fivefold to 18-fold over the next decade, depending on Wall Street's projections. On ...
MediPharm Labs Corp. ( OTCQX:MEDIF ) says it successfully completed its second set of export shipments of medical cannabis concentrate into Australia. More news on: MediPharm Labs Corp., Healthcare stocks news, Read more ...
MediPharm Labs receives permits for additional Canadian exports of medical cannabis concentrate to Australia and completes related shipments Australian exports represent a 137% greater volume compared to first export in second quarter 2019 TORONTO, Oct. 01, 2019 (GLOBE NEWSW...
MediPharm Labs ( OTCQX:MEDIF ) has entered into a multi-year supply agreement with TerrAscend Canada, a wholly-owned subsidiary of TerrAscend ( OTCQX:TRSSF ). More news on: MediPharm Labs Corp., TerrAscend Corp., Healthcare stocks news, Read more ...
MediPharm Labs to supply TerrAscend with large volumes of high-quality CBD and THC distillate Multi-Year supply agreement to support TerrAscend’s roll out of Canadian Cannabis 2.0 derivative products TORONTO, Sept. 25, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LAB...
First extraction-only company with supply agreement for export to Germany Second international distribution milestone further expands the Company’s global supply chain Demonstrates increasing international export potential in 2020 ...
News, Short Squeeze, Breakout and More Instantly...
MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders Canada NewsWire TORONTO , June 26, 2024 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical comp...
MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols Canada NewsWire MediPharm has licenced global manufacturing, distribution, and sales rights of the novel advanced medical cannabis technology from Remidose Aerosols. Product...